Skip to content
Journal articleRTP-00000470Open AccessDOI 10.1016/s0140-6736(17)32247-x

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

The Lancet · 2017 · Elsevier BV

6 views · 0 downloads

Citations by source

  • openalex1355

Counts differ by provider and are shown separately, never combined.